Compare Duke Energy Corp (DUK) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Duke Energy Corp vs State Street SPDR S&P Biotech ETF — how do they compare? Duke Energy Corp trades at $126.26 (market cap $98.52B), while State Street SPDR S&P Biotech ETF trades at $155.08. The key difference: Duke Energy Corp pays a 3.37% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Duke Energy Corp nearer its low. Which is the better fit depends on your goals.
| DUK | XBI | |
|---|---|---|
Market Cap | $98.52B | — |
Sector | Utilities | Broad Market / Factor |
52-Week High | $133.46 | $164.28 |
52-Week Low | $113.99 | $85.16 |
Enterprise Value | $188.56B | — |
Dividend Yield | 3.37% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Duke Energy (DUK) trades at $126.86, up 1.1% on the day, with a bullish technical outlook and consistent earnings beats in recent quarters. The stock shows stable revenue growth, with 2025 revenue reaching $32.24B and net income of $4.97B, supported by a 15.49% net margin. Recent news highlights a dividend increase to $1.085 per share and strong institutional interest, with 37.5% of analysts rating it a Buy.
The outlook remains positive with a consensus price target of $136.60, offering ~7.7% upside. Risks include high debt levels (46.17% debt-to-asset ratio) and regulatory pressures, but the company's defensive utility profile and dividend reliability provide stability amid market volatility.
XBI trades at $155.34, down 2.32% on the day, but maintains a bullish technical outlook with strong momentum indicators. The biotech ETF has gained significant attention after a 17% monthly surge, driven by sector rotation and M&A activity. Analyst coverage remains limited with a single hold rating, though recent news highlights biotech's strong performance amid market volatility.
The ETF offers exposure to biotech's resurgence with AI drug discovery and deal momentum as catalysts. However, high volatility and concentrated sector risk require careful position sizing. Current technical strength suggests potential for continued upside if sector momentum persists.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Duke Energy Corp
Duke Energy is one of the largest U.S. utilities, with regulated utilities in the Carolinas, Indiana, Florida, Ohio, and Kentucky that deliver electricity to nearly 8 million customers. Its natural gas utilities serve more than 1.5 million customers. Duke operates in three major segments: electric utilities and infrastructure
Read more on DUK →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
